These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24192582)

  • 1. NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss.
    Nevelsteen I; Van den Bergh A; Van der Mieren G; Vanderper A; Mubagwa K; Bult H; Herijgers P
    J Vasc Res; 2013; 50(6):486-97. PubMed ID: 24192582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury.
    Van der Mieren G; Nevelsteen I; Vanderper A; Oosterlinck W; Flameng W; Herijgers P
    Cardiovasc Diabetol; 2012 Aug; 11():89. PubMed ID: 22853195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice.
    Liang W; Tan CY; Ang L; Sallam N; Granville DJ; Wright JM; Laher I
    J Physiol Sci; 2008 Dec; 58(6):405-11. PubMed ID: 18845058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
    Resende AC; Pimentel AM; de Moura RS
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice.
    Zhang Y; Liu J; Tian XY; Wong WT; Chen Y; Wang L; Luo J; Cheang WS; Lau CW; Kwan KM; Wang N; Yao X; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):152-9. PubMed ID: 24202302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
    Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
    Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness.
    Van den Bergh A; Vanderper A; Vangheluwe P; Desjardins F; Nevelsteen I; Verreth W; Wuytack F; Holvoet P; Flameng W; Balligand JL; Herijgers P
    Cardiovasc Res; 2008 Jan; 77(2):371-9. PubMed ID: 18006491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril.
    Liu YH; You Y; Song T; Wu SJ; Liu LY
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):155-61. PubMed ID: 17703131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfur-containing angiotensin-converting enzyme inhibitor 3-thienylalanine-ornithyl-proline activates endothelial function and expression of genes involved in Renin-Angiotensin system.
    Chaudhary S; Seth MK; Vats ID; Kumar K; Biswas P; Karar J; Hussain ME; Pasha MA; Pasha S
    J Cardiovasc Pharmacol; 2013 Apr; 61(4):311-7. PubMed ID: 23232842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes.
    Okon EB; Chung AW; Zhang H; Laher I; van Breemen C
    Can J Physiol Pharmacol; 2007 May; 85(5):562-7. PubMed ID: 17632592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4.
    Liang CF; Liu JT; Wang Y; Xu A; Vanhoutte PM
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):777-84. PubMed ID: 23413427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C inhibition ameliorates functional endothelial insulin resistance and vascular smooth muscle cell hypersensitivity to insulin in diabetic hypertensive rats.
    Lu X; Bean JS; Kassab GS; Rekhter MD
    Cardiovasc Diabetol; 2011 Jun; 10():48. PubMed ID: 21635764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.
    Chalon S; Moreno H; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1999 Mar; 65(3):295-303. PubMed ID: 10096262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE-inhibition, but not weight reduction restores cardiomyocyte response to β-adrenergic stimulation in the metabolic syndrome.
    Nevelsteen I; Bito V; Van der Mieren G; Vanderper A; Van den Bergh A; Sipido KR; Mubagwa K; Herijgers P
    BMC Cardiovasc Disord; 2013 Jul; 13():51. PubMed ID: 23848952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition and food restriction restore delayed preconditioning in diabetic mice.
    Van der Mieren G; Nevelsteen I; Vanderper A; Oosterlinck W; Flameng W; Herijgers P
    Cardiovasc Diabetol; 2013 Feb; 12():36. PubMed ID: 23432808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension.
    Zhang LN; Vincelette J; Chen D; Gless RD; Anandan SK; Rubanyi GM; Webb HK; MacIntyre DE; Wang YX
    Eur J Pharmacol; 2011 Mar; 654(1):68-74. PubMed ID: 21187082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice.
    Winters B; Mo Z; Brooks-Asplund E; Kim S; Shoukas A; Li D; Nyhan D; Berkowitz DE
    J Appl Physiol (1985); 2000 Dec; 89(6):2382-90. PubMed ID: 11090593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.